HIGHLIGHTS
- who: Simona Camero and collaborators from the (IRCCS), Italy Siena University, Italy have published the research: Radioresistance in rhabdomyosarcomas: Much more than a question of dose, in the Journal: (JOURNAL)
- future: More research is necessary to fully understand the mechanisms of RMS radioresistance and improve the outcomes of patients with this deadly disease. used by cancer cells could lead to the development of promising targeted therapies able of weakening the different mechanisms of radioresistance also in the context of RMS.
SUMMARY
This choice is also supported by the fact that increasing . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.